A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
Clinical trial NCT05210868 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05210868
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2026-12-28
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.